Outlook Therapeutics (OTLK) FCF Margin (2015 - 2025)
Outlook Therapeutics (OTLK) reported FCF Margin of 13484.7% for Q3 2025, up 1805.62% quarter-over-quarter from 790.61% in Q2 2025.
Outlook Therapeutics (OTLK) FCF Margin (2015 - 2025) Analysis & Trends
Outlook Therapeutics (OTLK) has 6 years of FCF Margin data on file, last reported at 13484.7% in Q3 2025.
- FCF Margin for Q3 2025 came in at 13484.7%, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was 660.17% (changed N/A YoY), and the FY2025 annual result was 3666.65%, changed N/A from the prior year.
- FCF Margin rose to 13484.7% in Q3 2025 per OTLK's latest filing, from 790.61% in the prior quarter.
- Over five years, FCF Margin peaked at 13484.7% in Q3 2025 and troughed at 790.61% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 13,484.70% |
| Jun 30, 2025 | -790.61% |
| Sep 30, 2019 | -91.08% |
| Jun 30, 2019 | -1,895.78% |
| Mar 31, 2019 | -984.12% |
| Dec 31, 2018 | -938.35% |
| Sep 30, 2018 | -1,251.08% |
| Jun 30, 2018 | -1,127.54% |
| Mar 31, 2018 | -999.38% |
| Dec 31, 2017 | -1,262.64% |
| Sep 30, 2017 | 1.93% |
| Jun 30, 2017 | -1,920.45% |
| Mar 31, 2017 | -1,375.27% |
| Dec 31, 2016 | -1,933.89% |
| Sep 30, 2016 | -2,161.82% |
| Jun 30, 2016 | -3,332.90% |
| Mar 31, 2016 | -704.72% |
| Dec 31, 2015 | -1,244.00% |
| Sep 30, 2015 | -2,891.14% |
| Jun 30, 2015 | -1,044.51% |